Status:
NOT_YET_RECRUITING
Pulmonary Hypertension Screening in Scleroderma
Lead Sponsor:
Assiut University
Conditions:
PHTN in Scleroderma Patients
Eligibility:
All Genders
18-80 years
Brief Summary
Screening for pulmonary hypertension in scleroderma patients
Detailed Description
Scleroderma is a heterogenous connective tissue disorder characterized by fibrosis of the skin, with or without internal organ involvement. The aetiology of scleroderma may involve both environmental ...
Eligibility Criteria
Inclusion
- . Inclusion criteria: aga ≥18 years confirmed diagnosis of scleroderma
Exclusion
- aga \<18 years
- patients refused to participate
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT07186439
Start Date
September 1 2025
End Date
October 1 2026
Last Update
September 24 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.